未找到相关数据
Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment.
被引：0
作者：
Akce, Mehmet
El-Khoueiry, Anthony B.
Piha-Paul, Sarina Anne
Bacque, Emeline
Pan, Peng
Zhang, Zhi-Yi
Ewesuedo, Reginald
Gupta, Divya
Milton, Ashley
Judson, Patricia
O'Bryant, Cindy L.
机构：
[1] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Univ Southern Calif, Norris Comprehens Canc Ctr, Newport Beach, CA USA
[3] Univ Southern Calif, Hoag Mem Hosp, Presbyterian Canc Ctr, Newport Beach, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX 77030 USA
[5] GlaxoSmithKline, Waltham, MA USA
[6] Univ Colorado, Canc Ctr, Aurora, CO USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6054
引用
收藏
页数：2
相关论文